Misonix (NASDAQ:MSON) Announces Quarterly Earnings Results, Beats Expectations By $0.34 EPS

Misonix (NASDAQ:MSON) announced its quarterly earnings results on Thursday. The medical equipment provider reported $0.17 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.17) by $0.34, Fidelity Earnings reports. Misonix had a negative net margin of 19.01% and a negative return on equity of 25.99%. The firm had revenue of $11.15 million for the quarter.

NASDAQ MSON traded up $2.87 during trading on Friday, reaching $19.62. The company’s stock had a trading volume of 103,600 shares, compared to its average volume of 43,956. Misonix has a twelve month low of $13.87 and a twelve month high of $27.54. The business’s fifty day moving average price is $18.09 and its 200-day moving average price is $20.76.

MSON has been the topic of several research analyst reports. ValuEngine lowered shares of Misonix from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Canaccord Genuity reiterated a “buy” rating and set a $30.00 price target (up from $24.00) on shares of Misonix in a research note on Thursday, August 15th. Finally, BTIG Research reiterated a “buy” rating and set a $27.00 price target on shares of Misonix in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $28.50.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

About Misonix

Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells.

Further Reading: What are popular range trading strategies?

Earnings History for Misonix (NASDAQ:MSON)

Leave a Reply

Your email address will not be published. Required fields are marked *